# The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

> **NCT05499702** · PHASE2 · RECRUITING · sponsor: **Adrian Vella** · enrollment: 20 (estimated)

## Conditions studied

- Type2diabetes

## Interventions

- **BEHAVIORAL:** Caloric Restriction
- **DRUG:** Hyperglycemic clamp

## Key facts

- **NCT ID:** NCT05499702
- **Lead sponsor:** Adrian Vella
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-15
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05499702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05499702, "The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05499702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*